13F Data
13F filer · CIK 1582844

ACUTA CAPITAL PARTNERS, LLC

REDWOOD CITY, CA · filing since Q4 2014 · last filing Aug 14, 2026
Reported value
$143.5M
+$2.9M vs prior
Positions
23
New / sold out
5 / 9
Added / reduced
9 / 6
Turnover
23.6%
buys $33.5M · sells $43.7M
Top-10 weight
73.7%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewARRIVENT BIOPHARMA INC+218,694–+$7.6M
New4D MOLECULAR THERAPEUTICS INC+507,801–+$6.8M
AddedWHITEHAWK THERAPEUTICS INC+1,275,510+37.4%+$5.8M
NewAVALYN PHARMA INC+115,000–+$3.8M
NewARTIVA BIOTHERAPEUTICS INC+260,416–+$2.5M
AddedAVALO THERAPEUTICS INC+125,500+206.4%+$2.3M
AddedDESIGN THERAPEUTICS INC+136,664+93.7%+$2.0M
NewCONTINEUM THERAPEUTICS INC-A+63,095–+$1.0M
AddedTAYSHA GENE THERAPIES INC+122,344+27.8%+$833.2K
AddedMOONLAKE IMMUNOTHERAPEUTICS+23,892+12.5%+$465.2K
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outTERNS PHARMACEUTICALS INC-495,772-100.0%$-26.1M
Sold outOCULIS HOLDING AG-98,339-100.0%$-2.6M
Sold outREVOLUTION MEDICINES INC-26,069-100.0%$-2.5M
Sold out4D MOLECULAR THERAPEUTICS INC-242,255-100.0%$-2.3M
ReducedERASCA INC-89,376-25.2%$-1.6M
Sold outIDEAYA BIOSCIENCES INC-48,234-100.0%$-1.6M
ReducedTANGO THERAPEUTICS INC-50,882-11.5%$-1.6M
ReducedBRIGHT MINDS BIOSCIENCES INC-19,251-17.2%$-1.4M
Sold outENTRADA THERAPEUTICS INC-89,358-100.0%$-1.1M
ReducedPRAXIS PRECISION MEDICINES I-2,105-2.5%$-704.7K
5 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2014: $148.0MQ1 2015: $118.7MQ2 2015: $161.7MQ3 2015: $172.7MQ4 2015: $209.1MQ1 2016: $178.8MQ2 2016: $208.1MQ3 2016: $266.3MQ4 2016: $268.9MQ1 2017: $421.8MQ2 2017: $357.3MQ3 2017: $558.0MQ4 2017: $529.7MQ1 2018: $612.3MQ2 2018: $561.7MQ3 2018: $280.4MQ4 2018: $131.1MQ1 2019: $210.3MQ2 2019: $281.2MQ3 2019: $138.5MQ4 2019: $403.8MQ1 2020: $206.3MQ2 2020: $346.1MQ3 2020: $368.2MQ4 2020: $367.5MQ1 2021: $277.3MQ2 2021: $250.2MQ3 2021: $283.4MQ4 2021: $237.9MQ1 2022: $214.0MQ2 2022: $179.5MQ3 2022: $232.2MQ4 2022: $162.5MQ1 2023: $135.7MQ2 2023: $147.6MQ3 2023: $138.4MQ4 2023: $177.7MQ1 2024: $153.9MQ2 2024: $118.7MQ3 2024: $123.5MQ4 2024: $99.4MQ1 2025: $86.2MQ2 2025: $71.6MQ3 2025: $96.8MQ4 2025: $147.3MQ1 2026: $140.6MQ2 2026: $143.5M
Q4 2014Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1PRAXIS PRECISION MEDICINES ICOM NEW82,796$27.7M19.32%
2WHITEHAWK THERAPEUTICS INCCOM4,685,912$21.5M14.96%
3TANGO THERAPEUTICS INCCOM390,949$12.2M8.52%
4SUTRO BIOPHARMA INCCOM270,251$9.0M6.25%
5ARRIVENT BIOPHARMA INCCOM218,694$7.6M5.29%
64D MOLECULAR THERAPEUTICS INCCOM507,801$6.8M4.71%
7BRIGHT MINDS BIOSCIENCES INCCOM NEW92,745$6.5M4.54%
8OCULAR THERAPEUTIX INCCOM532,481$5.2M3.64%
9ERASCA INCCOM265,199$4.9M3.39%
10SURROZEN INCCOM NEW173,395$4.5M3.14%
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.